格隆汇9月30日丨丰山集团(603810.SH)公布股票交易异常波动暨风险提示公告，公司关注到近期部分媒 体报道称公司涉及"固态电池"热点概念。公司目前主营业务仍以原药及制剂的生产、研发、销售为主， 公司主营业务未发生变化，且丰山全诺目前主要销售锂离子电解液，钠离子电解液占比相对较小，且销 售不涉及固态电池电解质材料。截至2025年上半年，钠离子电解液销售额占公司合并报表营业收入的比 例为0.01%。此外，关于清华大学张强教授团队近期发表的重要研究成果，与我公司委托其开展的研究 开发项目并非同一项研发项目。目前，公司与清华大学合作处于初步研究开发启动阶段，合同金额较 小，技术开发项目周期至2028年12月31日，项目周期较长，后续研发成果及成果的商业化存在较大的不 确定性。请广大投资者在决策时务必谨慎，并注意防范潜在的投资风险。 ...

Core Viewpoint - Fengshan Group (603810.SH) clarifies that its main business remains focused on the production, research, and sales of raw medicines and formulations, despite media reports linking the company to the "solid-state battery" concept [1] Business Operations - The company emphasizes that its main operations have not changed, and its subsidiary Fengshan Quannuo primarily sells lithium-ion electrolytes, with sodium-ion electrolytes accounting for a relatively small proportion of sales [1] - As of the first half of 2025, sodium-ion electrolyte sales are projected to represent only 0.01% of the company's consolidated revenue [1] Research and Development - The recent important research results published by Professor Zhang Qiang's team from Tsinghua University are not related to the research and development project commissioned by the company [1] - The collaboration with Tsinghua University is still in the preliminary research and development phase, with a small contract amount, and the technical development project is expected to last until December 31, 2028, indicating significant uncertainty regarding future research outcomes and commercialization [1]

智通财经APP讯，丰山集团(603810.SH)发布股票交易异常波动暨风险提示公告称，公司关注到近期部 分媒体报道称公司涉及"固态电池"热点概念。公司目前主营业务仍以原药及制剂的生产、研发、销售为 主，公司主营业务未发生变化，且公司控股子公司丰山全诺目前主要销售锂离子电解液，钠离子电解液 占比相对较小，且销售不涉及固态电池电解质材料。截至2025年上半年，钠离子电解液销售额占公司合 并报表营业收入的比例为0.01%。此外，关于清华大学张强教授团队近期发表的重要研究成果，与我公 司委托其开展的研究开发项目并非同一项研发项目。目前，公司与清华大学合作处于初步研究开发启动 阶段，合同金额较小，技术开发项目周期至2028年12月31日，后续研发成果及成果的商业化存在较大的 不确定性。 ...

格隆汇9月30日｜丰山集团(603810.SH)发布股票交易异常波动暨风险提示公告称，公司关注到近期部分 媒体报道称公司涉及"固态电池"热点概念。公司目前主营业务仍以原药及制剂的生产、研发、销售为 主，公司主营业务未发生变化，且公司控股子公司丰山全诺目前主要销售锂离子电解液，钠离子电解液 占比相对较小，且销售不涉及固态电池电解质材料。截至2025年上半年，钠离子电解液销售额占公司合 并报表营业收入的比例为0.01%。此外，关于清华大学张强教授团队近期发表的重要研究成果，与我公 司委托其开展的研究开发项目并非同一项研发项目。目前，公司与清华大学合作处于初步研究开发启动 阶段，合同金额较小，技术开发项目周期至2028年12月31日，后续研发成果及成果的商业化存在较大的 不确定性。敬请广大投资者关注相关风险，理性决策，审慎投资。 ...

丰山集团9月30日公告，公司关注到近期部分媒体报道称公司涉及"固态电池"热点概念。公司目前主营 业务仍以原药及制剂的生产、研发、销售为主，公司主营业务未发生变化，且公司控股子公司丰山全诺 目前主要销售锂离子电解液，钠离子电解液占比相对较小，且销售不涉及固态电池电解质材料。截至 2025年上半年，钠离子电解液销售额占公司合并报表营业收入的比例为0.01%。此外，关于清华大学张 强教授团队近期发表的重要研究成果，与我公司委托其开展的研究开发项目并非同一项研发项目。目 前，公司与清华大学合作处于初步研究开发启动阶段，合同金额较小，技术开发项目周期至2028年12月 31日，后续研发成果及成果的商业化存在较大的不确定性。敬请广大投资者关注相关风险，理性决策， 审慎投资。 ...

每经AI快讯，9月30日，丰山集团(603810.SH)发布股票交易异常波动暨风险提示公告称，公司关注到近 期部分媒体报道称公司涉及"固态电池"热点概念。公司目前主营业务仍以原药及制剂的生产、研发、销 售为主，公司主营业务未发生变化，且公司控股子公司丰山全诺目前主要销售锂离子电解液，钠离子电 解液占比相对较小，且销售不涉及固态电池电解质材料。截至2025年上半年，钠离子电解液销售额占公 司合并报表营业收入的比例为0.01%。此外，关于清华大学张强教授团队近期发表的重要研究成果，与 我公司委托其开展的研究开发项目并非同一项研发项目。目前，公司与清华大学合作处于初步研究开发 启动阶段，合同金额较小，技术开发项目周期至2028年12月31日，后续研发成果及成果的商业化存在较 大的不确定性。敬请广大投资者关注相关风险，理性决策，审慎投资。 ...

人民财讯9月30日电，丰山集团（603810）9月30日发布股票交易异常波动暨风险提示，公司关注到近期 部分媒体报道称公司涉及"固态电池"热点概念。公司目前主营业务仍以原药及制剂的生产、研发、销售 为主，公司主营业务未发生变化，且公司控股子公司丰山全诺目前主要销售锂离子电解液，钠离子电解 液占比相对较小，且销售不涉及固态电池电解质材料。截至2025年上半年，钠离子电解液销售额占公司 合并报表营业收入的比例为0.01%。此外，关于清华大学张强教授团队近期发表的重要研究成果，与我 公司委托其开展的研究开发项目并非同一项研发项目。目前，公司与清华大学合作处于初步研究开发启 动阶段，合同金额较小，技术开发项目周期至2028年12月31日，后续研发成果及成果的商业化存在较大 的不确定性。 ...

Core Viewpoint - Jiangsu Fengshan Group Co., Ltd. maintains an AA- credit rating with a stable outlook, reflecting its strong product structure and customer quality, despite facing challenges in profitability and industry conditions [4][9]. Company Overview - The company primarily engages in the research, production, and sales of pesticide active ingredients, formulations, and fine chemical intermediates [11]. - The fine chemical segment has entered trial production, enhancing the company's product chain and competitiveness [6][11]. Financial Performance - Total assets as of March 2025 are 27.81 billion, with equity attributable to shareholders at 15.91 billion [4]. - Revenue for 2023 is reported at 3.22 billion, a decline from 10.44 billion in 2022, with a net profit of 0.15 billion, recovering from a loss of 0.42 billion in 2022 [4][5]. - The company’s operating cash flow has been negative, indicating challenges in cash generation [4]. Industry Environment - The pesticide industry is currently at a cyclical low, with a projected slight decline in revenue for 2024, while the net profit is expected to remain a loss of 0.39 billion [6][9]. - The global pesticide market is expected to grow from 790.6 billion in 2024 to 1,185.1 billion by 2031, driven by increasing food demand and pest control needs [14]. Risks and Challenges - The company faces risks related to the commercialization of sodium-ion electrolyte products, which are not progressing as expected, leading to underutilization of production capacity [7][8]. - Environmental and safety production risks are heightened due to stricter regulations in the chemical industry [8][9]. Market Position - The company has a competitive edge in its core pesticide products, with significant market share in active ingredients like Fluorochloromethane and Quinclorac [15][16]. - The sales concentration remains low, with a diverse customer base, reducing dependency on a few clients [19]. Future Outlook - The credit rating agency maintains a stable outlook for the company, anticipating gradual recovery in market demand and pricing for its main products [9][12]. - The company is actively managing inventory and production to align with market conditions, indicating a strategic approach to navigating current challenges [19].

Core Viewpoint - The global sodium-ion battery industry is expected to experience explosive growth in 2024, with the demand for electrolytes reaching 2,400 tons, a year-on-year increase of 90.5%, driven by the large-scale application of sodium-ion batteries in energy storage and low-speed electric vehicles [1][3]. Downstream Demand Drivers - The energy storage market is booming, with sodium-ion batteries becoming popular due to their low cost, high safety, and resource availability, supported by global renewable energy storage policies [3]. - The low-speed electric vehicle market is expanding, with leading domestic companies like Yadea and Aima achieving over 20% penetration of sodium-ion models, and partnerships established between companies like CATL and vehicle manufacturers [3]. - Policy and capital are driving growth, with subsidies for sodium-ion batteries introduced in China, the EU, and India, leading to a 120% year-on-year increase in financing for leading companies [4]. Market Competition Landscape - Sodium-ion electrolyte production lines can generally be used interchangeably with lithium-ion electrolyte production lines, resulting in sufficient capacity for sodium-ion electrolytes as long as there is downstream demand [5]. - The market competition landscape has shifted significantly, with Zhuhai Saiwei leading in sodium-ion electrolyte shipments, followed by Jiangsu Langu and BYD, which primarily produces for its own use [6][7]. Market Outlook for 2025-2030 - The demand for sodium-ion electrolytes is expected to exceed 9,000 tons in 2025, representing a year-on-year growth of 275%, driven by the large-scale implementation of energy storage projects and the introduction of sodium-ion hybrid vehicles by companies like BYD and NIO [8][9]. - 2025 is anticipated to be a critical year for the commercialization potential of the sodium-ion industry, with technological advancements and capacity expansion occurring simultaneously [9].